Do elderly systolic heart failure patients benefit from beta blockers to the same extent as the non-elderly?: Meta-analysis of >12,000 patients in large-scale clinical trials

被引:67
作者
Dulin, BR
Haas, SJ
Abraham, WT
Krum, H
机构
[1] Monash Univ, Alfred Hosp, NHMRC Ctr Clin Res Excellence Therapeut, Dept Epidemiol, Melbourne, Vic 3004, Australia
[2] Monash Univ, Alfred Hosp, NHMRC Ctr Clin Res Excellence Therapeut, Dept Prevent Med & Med, Melbourne, Vic 3004, Australia
[3] Davis Heart & Lung Res Inst, Columbus, OH USA
[4] Ohio State Univ, Div Cardiovasc Med, Columbus, OH 43210 USA
关键词
D O I
10.1016/j.amjcard.2004.11.052
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A meta-analysis of all-cause mortality data involving elderly and non-elderly chronic heart failure patients from 5 completed beta-blocker trials revealed that elderly and non-elderly chronic heart failure patients derived considerable prognostic benefit from beta-blacker therapy without a statistically significant difference in mortality reduction between the 2 groups. (c) 2005 by Excerpta Medica Inc.
引用
收藏
页码:896 / 898
页数:3
相关论文
共 12 条
  • [1] ALLADA CS, 2002, J AM COLL CARDIOL S, V39, P1113
  • [2] A COMPARISON OF STATISTICAL-METHODS FOR COMBINING EVENT RATES FROM CLINICAL-TRIALS
    BERLIN, JA
    LAIRD, NM
    SACKS, HS
    CHALMERS, TC
    [J]. STATISTICS IN MEDICINE, 1989, 8 (02) : 141 - 151
  • [3] Deeks J.J., 2008, Systematic Reviews in Health Care: Meta-Analysis in Context, Second Edition, P285
  • [4] Eichhorn E, 2001, NEW ENGL J MED, V344, P1659
  • [5] Results from post-hoc analyses of the CIBIS II trial: effect of bisoprolol in high-risk patient groups with chronic heart failure
    Erdmann, E
    Lechat, P
    Verkenne, P
    Wiemann, H
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2001, 3 (04) : 469 - 479
  • [6] FASTTRACK Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS)
    Flather, MD
    Shibata, MC
    Coats, AJS
    Van Veldhuisen, DJ
    Parkhomenko, A
    Borbola, J
    Cohen-Solal, A
    Dumitrascu, D
    Ferrari, R
    Lechat, P
    Soler-Soler, J
    Tavazzi, L
    Spinarova, L
    Toman, J
    Böhm, M
    Anker, SD
    Thompson, SG
    Poole-Wilson, PA
    [J]. EUROPEAN HEART JOURNAL, 2005, 26 (03) : 215 - 225
  • [7] Strengths and limitations of meta-analysis: Larger studies may be more reliable
    Flather, MD
    Farkouh, ME
    Pogue, JM
    Yusuf, S
    [J]. CONTROLLED CLINICAL TRIALS, 1997, 18 (06): : 568 - 579
  • [8] Hjalmarson Å, 1999, LANCET, V353, P2001
  • [9] Lechat P, 1999, LANCET, V353, P9
  • [10] Effect of carvedilol on survival in severe chronic heart failure.
    Packer, M
    Coats, AJS
    Fowler, MB
    Katus, HA
    Krum, H
    Mohacsi, P
    Rouleau, JL
    Tendera, M
    Castaigne, A
    Roecker, EB
    Schultz, MK
    DeMets, DL
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (22) : 1651 - 1658